{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:06:30Z","timestamp":1791511590001,"version":"4.3.4"},"reference-count":181,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":1874,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s13311-018-0640-5","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T11:12:36Z","timestamp":1529406756000},"page":"697-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Treatment of Refractory and Super-refractory Status Epilepticus"],"prefix":"10.1016","volume":"15","author":[{"given":"Samhitha","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.","family":"Drislane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-018-0640-5_bib1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus. - Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It's time to revise the definition of status epilepticus","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-018-0640-5_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-510X(03)00036-4","article-title":"Treatment of status epilepticus: a survey of neurologists","volume":"211","author":"Claassen","year":"2003","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1007\/s13311-018-0640-5_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2009.02.027","article-title":"Status epilepticus: a critical review","volume":"15","author":"Knake","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-018-0640-5_bib8","series-title":"Status epilepticus","first-page":"607","article-title":"Critical care of the patient in status epilepticus. Chap","author":"Bleck","year":"2006"},{"key":"10.1007\/s13311-018-0640-5_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0036-1592357","article-title":"Status epilepticus in the intensive care unit","volume":"36","author":"Bermeo-Ovalle","year":"2016","journal-title":"Semin Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus. Frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-018-0640-5_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.12996","article-title":"Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison","volume":"56","author":"Alvarez","year":"2015","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilespia"},{"key":"10.1007\/s13311-018-0640-5_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archneur.62.9.1428","article-title":"A \u201cmalignant\u201d variant of status epilepticus","volume":"62","author":"Holtkamp","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/WCO.0b013e328042bacb","article-title":"The anaesthetic and intensive care of status epilepticus","volume":"20","author":"Holtkamp","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.37.3.500","article-title":"Pentobarbital treatment of refractory status epilepticus","volume":"37","author":"Rashkin","year":"1987","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib18","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1007\/s13311-018-0640-5_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","article-title":"Incidence and mortality of super-refractory status epilepticus in adults","volume":"49","author":"Kantanen","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-018-0640-5_bib20","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/01.WNL.0000125184.88797.62","article-title":"Detection of electrographic seizures with continuous EEG monitoring in critically ill patients","volume":"62","author":"Claassen","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(90)90065-4","article-title":"Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus","volume":"5","author":"Treiman","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0920-1211(94)90021-3","article-title":"Clinical implications of generalized electrographic status epilepticus","volume":"19","author":"Drislane","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.42.1.100","article-title":"Clinical and EEG features of status epilepticus in comatose patients","volume":"42","author":"Lowenstein","year":"1992","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib24","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn 2+ sensitivity of hippocampal dentate granule cell GABA-A receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-018-0640-5_bib25","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharamacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-018-0640-5_bib26","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci"},{"issue":"suppl 4","key":"10.1007\/s13311-018-0640-5_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.2007.00803.x","article-title":"Advances in the pathophysiology of status epilepticus","volume":"115","author":"Chen","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1007\/s13311-018-0640-5_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1157.2000.tb01572.x","article-title":"Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptides neuromodulators","volume":"41","author":"Wasterlain","year":"2000","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib29","series-title":"Nonconvulsive status epilepticus","first-page":"81","article-title":"Pathophysiology of nonconvulsive status epilepticus. Chap 7","author":"Kapur","year":"2009"},{"key":"10.1007\/s13311-018-0640-5_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1007\/s13311-018-0640-5_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res"},{"key":"10.1007\/s13311-018-0640-5_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1212\/WNL.43.3_Part_1.483","article-title":"Status epilepticus at an urban public hospital in the 1980's","volume":"43","author":"Lowenstein","year":"1993","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(91)90094-V","article-title":"The relationship between electrographic seizure activity and neuronal injury","volume":"10","author":"Lowenstein","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-1211(93)90077-K","article-title":"Analysis of electrocardiographic changes in status epilepticus","volume":"14","author":"Boggs","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CCM.0000000000002843","article-title":"Acute systemic complications of convulsive status epilepticus \u2013 a systematic review","volume":"46","author":"Sutter","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-018-0640-5_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.1973.00490260026003","article-title":"Systemic factors and epileptic brain damage","volume":"29","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-018-0640-5_bib38","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.ejrad.2013.05.020","article-title":"Seizure induced brain lesions: a wide spectrum of variably reversible MRI abnormalities","volume":"82","author":"Cianfoni","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1007\/s13311-018-0640-5_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/jnnp.2003.015354","article-title":"Evolution of MRI changes and development of bilateral hippocampal sclerosis during long lasting generalised status epilepticus","volume":"75","author":"Pohlmann-Eden","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"suppl 4","key":"10.1007\/s13311-018-0640-5_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.0013-9580.2004.04014.x","article-title":"Status epilepticus and periictal imaging","volume":"45","author":"Cole","year":"2004","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiology.194.1.7997562","article-title":"The hippocampus in status epilepticus: demonstration of signal intensity and morphologic changes with sequential fast spin echo MR imaging","volume":"194","author":"Tien","year":"1995","journal-title":"Radiology"},{"key":"10.1007\/s13311-018-0640-5_bib42","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1528-1157.1997.tb01222.x","article-title":"Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus","volume":"38","author":"Wieshmann","year":"1997","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13054-015-0914-9","article-title":"Functional outcome of prolonged refractory status epilepticus","volume":"19","author":"Lai","year":"2015","journal-title":"Crit Care"},{"key":"10.1007\/s13311-018-0640-5_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000269791.96189.70","article-title":"In-hospital mortality of generalized convulsive status epilepticus: a large US sample","volume":"69","author":"Koubeissi","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/WNP.0000000000000223","article-title":"Is favorable outcome possible after prolonged refractory status epilepticus?","volume":"33","author":"Alvarez","year":"2016","journal-title":"J Clin Neurophysiol"},{"key":"10.1007\/s13311-018-0640-5_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12028-012-9788-8","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus","volume":"18","author":"Finn\u00e9 Lenoir","year":"2013","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yebeh.2011.07.013","article-title":"Survivors and non-survivors of prolonged status epilepticus","volume":"22","author":"Drislane","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-018-0640-5_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12028-013-9823-4","article-title":"Clinical outcomes following prolonged refractory status epilepticus (PRSE)","volume":"18","author":"Kilbride","year":"2013","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","article-title":"Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours","volume":"50","author":"Drislane","year":"2009","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib51","series-title":"Status epilepticus. A clinical perspective","first-page":"201","article-title":"Treatment of refractory and super-refractory status epilepticus. Chap 17","author":"Hocker","year":"2017"},{"key":"10.1007\/s13311-018-0640-5_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus","volume":"17","author":"Singhi","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus","volume":"82","author":"Fernandez","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib54","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2174\/1381612043382846","article-title":"Propofol: therapeutic indications and side-effects","volume":"10","author":"Marik","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1007\/s13311-018-0640-5_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2011.01.006","article-title":"Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome","volume":"94","author":"Power","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib56","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1097\/CCM.0b013e3181b08ac7","article-title":"Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience","volume":"37","author":"Iyer","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-018-0640-5_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2110-5820-3-32","article-title":"Propofol infusion syndrome resuscitation with extracorporeal life support: a case report and review of the literature","volume":"3","author":"Mayette","year":"2013","journal-title":"Ann Intensive Care"},{"key":"10.1007\/s13311-018-0640-5_bib58","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.0013-9580.2004.01904.x","article-title":"Propofol treatment of refractory status epilepticus: a study of 31 episodes","volume":"45","author":"Rossetti","year":"2004","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib59","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.1970.03170200079022","article-title":"Reversible iso-electric EEG in barbiturate coma","volume":"212","author":"Kirshbaum","year":"1970","journal-title":"JAMA"},{"key":"10.1007\/s13311-018-0640-5_bib60","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/cc13883","article-title":"Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study","volume":"18","author":"Pugin","year":"2014","journal-title":"Crit Care"},{"key":"10.1007\/s13311-018-0640-5_bib61","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.38.7.1035","article-title":"Very-high-dose phenobarbital for refractory status epilepticus in children","volume":"38","author":"Crawford","year":"1988","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12028-010-9445-z","article-title":"Lee JW. A randomized trial for the treatment of refractory status epilepticus","volume":"14","author":"Rossetti","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/WNL.38.3.395","article-title":"Barbiturate anesthesia in the treatment of status epilepticus. Clinical experience with 14 patients","volume":"38","author":"Lowenstein","year":"1988","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-015-0589-2","article-title":"Treatment of super-refractory status epilepticus","volume":"15","author":"Bayrlee","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1007\/s13311-018-0640-5_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12028-008-9168-6","article-title":"Bowel ischemia: a rare complication of thiopental treatment for status epilepticus","volume":"10","author":"Cereda","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12028-008-9072-0","article-title":"Massive tongue swelling in refractory status epilepticus treated with high-dose pentobarbital","volume":"10","author":"Ji","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yebeh.2015.04.010","article-title":"Preliminary results of the global audit of treatment of refractory status epilepticus","volume":"49","author":"Ferlisi","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-018-0640-5_bib68","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00134-013-2938-4","article-title":"Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM","volume":"39","author":"Claassen","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1007\/s13311-018-0640-5_bib69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WNP.0000000000000166","article-title":"Consensus statement on continuous EEG in critically ill adults and children, part I: indications","volume":"32","author":"Herman","year":"2015","journal-title":"J Clin Neurophysiol"},{"key":"10.1007\/s13311-018-0640-5_bib70","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1528-1157.1999.tb00775.x","article-title":"Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus","volume":"40","author":"Krishnamurthy","year":"1999","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib71","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","article-title":"Refractory status epilepticus: effect of treatment aggressiveness on prognosis","volume":"62","author":"Rossetti","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib72","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","article-title":"Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus","volume":"39","author":"DeLorenzo","year":"1998","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib73","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.54.2.340","article-title":"Prevalence of nonconvulsive status epilepticus in comatose patients","volume":"54","author":"Towne","year":"2000","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0896-6974(94)00003-I","article-title":"Clinical significance and outcome of subclinical status epilepticus in adults","volume":"8","author":"So","year":"1995","journal-title":"J Epilepsy"},{"key":"10.1007\/s13311-018-0640-5_bib75","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.57.6.1036","article-title":"Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus","volume":"57","author":"Claassen","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib76","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/WNL.40.11.1689","article-title":"Prolonged confusion following convulsions due to generalized non-convulsive status epilepticus","volume":"40","author":"Fagan","year":"1990","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib77","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1528-1157.1996.tb00039.x","article-title":"Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus","volume":"37","author":"Krishnamurthy","year":"1996","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib78","series-title":"Status epilepticus. A clinical perspective","first-page":"43","article-title":"Periodic EEG patterns. Chap 7","author":"Grossman","year":"2017"},{"key":"10.1007\/s13311-018-0640-5_bib79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.WNP.0000158701.89576.4C","article-title":"The ACNS subcommittee on research terminology for continuous EEG monitoring: Proposed standardized terminology for rhythmic and periodic EEG patterns encountered in critically ill patients","volume":"22","author":"Hirsch","year":"2005","journal-title":"J Clin Neurophysiol"},{"key":"10.1007\/s13311-018-0640-5_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.WNP.0000158699.78529.AF","article-title":"Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns","volume":"22","author":"Chong","year":"2005","journal-title":"J Clin Neurophysiol"},{"key":"10.1007\/s13311-018-0640-5_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1212\/WNL.47.1.83","article-title":"An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality","volume":"47","author":"Young","year":"1996","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib82","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.clinph.2014.11.008","article-title":"Inter-rater agreement on identification of electrographic seizures and periodic discharges in ICU EEG recordings","volume":"126","author":"Halford","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"10.1007\/s13311-018-0640-5_bib83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","article-title":"Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus \u2013 approach to clinical application","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"suppl 3","key":"10.1007\/s13311-018-0640-5_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2012.03593.x","article-title":"Electroencephalographic criteria for nonconvulsive status epilepticus: Synopsis and comprehensive survey","volume":"53","author":"Sutter","year":"2012","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1157.1994.tb02910.x","article-title":"Nonconvulsive status epilepticus: EEG analysis in a large series","volume":"35","author":"Granner","year":"1994","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1528-1157.1999.tb02069.x","article-title":"The EEG and prognosis in status epilepticus","volume":"40","author":"Nei","year":"1999","journal-title":"Epilepsia"},{"issue":"suppl 3","key":"10.1007\/s13311-018-0640-5_bib87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1528-1157.43.s.3.9.x","article-title":"Is it status?","volume":"43","author":"Brenner","year":"2002","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib88","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11910-014-0452-x","article-title":"Refractory and super-refractory status epilepticus \u2013 an update","volume":"14","author":"Hocker","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1007\/s13311-018-0640-5_bib89","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1528-1157.1997.tb00073.x","article-title":"Short-term mortality after a first episode of status epilepticus","volume":"38","author":"Logroscino","year":"1997","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib90","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","article-title":"Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation","volume":"77","author":"Rossetti","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-018-0640-5_bib91","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2008.10.002","article-title":"Etiology of a short-term mortality in the group of 750 patients with 920 episodes of status epilepticus within a period of 10 years (1988\u20131997)","volume":"18","author":"Sokic","year":"2009","journal-title":"Seizure"},{"key":"10.1007\/s13311-018-0640-5_bib92","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","article-title":"Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study","volume":"82","author":"Sutter","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib93","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/CCM.0000000000000881","article-title":"Status epilepticus: impact of therapeutic coma on outcome","volume":"43","author":"Marchi","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-018-0640-5_bib94","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0000000000003224","article-title":"Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study","volume":"87","author":"Alvarez","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib95","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.wnl.0000223352.71621.97","article-title":"A clinical score for prognosis of status epilepticus in adults","volume":"66","author":"Rossetti","year":"2006","journal-title":"Neurology"},{"issue":"suppl 2","key":"10.1007\/s13311-018-0640-5_bib96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1528-1157.44.s.2.5.x","article-title":"Acute management of seizures in the syndromes of idiopathic generalized epilepsies","volume":"44","author":"Wheless","year":"2003","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib97","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1972.tb04565.x","article-title":"Absence status: a reappraisal following review of thirty-eight patients","volume":"13","author":"Andermann","year":"1972","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1528-1167.2005.00316.x","article-title":"Status epilepticus in idiopathic generalized epilepsy","volume":"46","author":"Shorvon","year":"2005","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib99","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1212\/WNL.33.12.1545","article-title":"Partial complex status epilepticus","volume":"33","author":"Ballenger","year":"1983","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(07)70074-1","article-title":"Non convulsive status epilepticus in adults: clinical forms and treatment","volume":"6","author":"Meierkord","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jnnp.61.1.93","article-title":"Non-convulsive status epilepticus: causes, treatment, and outcome in 65 patients","volume":"61","author":"Scholtes","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-018-0640-5_bib102","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.28.9.863","article-title":"Prolonged partial complex status epilepticus: EEG and behavioral observations","volume":"28","author":"Engel","year":"1978","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib103","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1528-1167.2007.01157.x","article-title":"Cognitive deficits during status epilepticus and time course of recovery: a case report","volume":"48","author":"van Paesschen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib104","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.45.8.1499","article-title":"Complex partial status epilepticus accompanied by serious morbidity and mortality","volume":"45","author":"Krumholz","year":"1995","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archneur.1966.00470180003001","article-title":"Epilepsia partialis continua. A clinical, electroencephalographic, and neuropathological study of nine cases","volume":"15","author":"Juul-Jensen","year":"1966","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib106","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1528-1167.2010.02974.x","article-title":"Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases","volume":"52","author":"Mameniskiene","year":"2011","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib107","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/WNL.44.6.1030","article-title":"Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients","volume":"44","author":"Hart","year":"1994","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib108","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/jnnp.57.7.835","article-title":"Complex partial status epilepticus: a recurrent problem","volume":"57","author":"Cockerell","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-018-0640-5_bib109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1528-1157.2002.28101.x","article-title":"Multiple subpial transaction for intractable partial epilepsy: an international meta-analysis","volume":"43","author":"Spencer","year":"2002","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1212\/01.WNL.0000150580.40019.63","article-title":"Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis","volume":"64","author":"Alexopoulos","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib111","series-title":"Epilepsy: a comprehensive textbook","first-page":"725","article-title":"Myoclonic status epilepticus","author":"Ohtahara","year":"2008"},{"key":"10.1007\/s13311-018-0640-5_bib112","series-title":"Status epilepticus. A clinical perspective","first-page":"139","article-title":"Myoclonic status epilepticus. Chap 12","author":"Serafini","year":"2017"},{"key":"10.1007\/s13311-018-0640-5_bib113","series-title":"Status epilepticus. A clinical perspective","first-page":"155","article-title":"Anoxic myoclonic status epilepticus. Chap 13","author":"Bauer","year":"2017"},{"key":"10.1007\/s13311-018-0640-5_bib114","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1212\/01.wnl.0000343006.60851.62","article-title":"Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia","volume":"72","author":"Rossetti","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1212\/01.wnl.0000265819.36639.e0","article-title":"Status epilepticus. An independent outcome predictor after cerebral anoxia","volume":"69","author":"Rossetti","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib116","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12028-012-9785-y","article-title":"Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus","volume":"18","author":"Ferguson","year":"2013","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib117","series-title":"Status epilepticus. A clinical perspective","first-page":"227","article-title":"Evolving concepts of nonconvulsive status epilepticus. Chap 19","author":"Drislane","year":"2017"},{"key":"10.1007\/s13311-018-0640-5_bib118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pediatrneurol.2007.05.012","article-title":"Nonconvulsive status epilepticus in a pediatric intensive care unit","volume":"37","author":"Abend","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib119","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000082653.40257.0B","article-title":"Assessment of acute morbidity and mortality in nonconvulsive status epilepticus","volume":"61","author":"Shneker","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib120","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/brain\/awu042","article-title":"Seizure burden is independently associated with short term outcome in critically ill children","volume":"137","author":"Payne","year":"2014","journal-title":"Brain"},{"key":"10.1007\/s13311-018-0640-5_bib121","series-title":"Status epilepticus. A clinical perspective","first-page":"333","article-title":"pediatric status epilepticus: initial management and the special syndromes of status epilepticus in children. Chap 27","author":"Riviello","year":"2017"},{"key":"10.1007\/s13311-018-0640-5_bib122","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archneur.1971.00480330070006","article-title":"Subclinical \u201celectrical status epilepticus\u201d induced by sleep in children. A clinical and electroencephalographic study of six cases","volume":"24","author":"Patry","year":"1971","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib123","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1007\/s13311-018-0640-5_bib124","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.29.11.1474","article-title":"Intravenous phenytoin in acute treatment of seizures","volume":"29","author":"Cranford","year":"1979","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0920-1211(97)00054-5","article-title":"Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin","volume":"28","author":"Ramsay","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib126","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1528-1167.2007.00989.x","article-title":"Safety of rapid intravenous loading of valproate","volume":"48","author":"Limdi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib127","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1007\/s13311-018-0640-5_bib128","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1007\/s13311-018-0640-5_bib129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1528-1157.1999.tb00814.x","article-title":"Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults","volume":"40","author":"Konig","year":"1999","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1007\/s13311-018-0640-5_bib131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-018-0640-5_bib132","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11940-011-0148-3","article-title":"Treatment of pediatric status epilepticus","volume":"13","author":"Loddenkemper","year":"2011","journal-title":"Curr Treat Options Neurol"},{"issue":"suppl 8","key":"10.1007\/s13311-018-0640-5_bib133","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/epi.12027","article-title":"Current position of phenobarbital in epilepsy and its future","volume":"53","author":"Brodie","year":"2012","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib134","first-page":"1829","article-title":"Adjunctive enteral phenobarbital for adult status epilepticus: a brief report","volume":"9","author":"Tiamkao","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"51","key":"10.1007\/s13311-018-0640-5_bib135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3325\/cmj.2010.51.215","article-title":"Single enteral loading dose of phenobarbital for achieving its therapeutic serum levels in neonates","volume":"15","author":"Turhan","year":"2010","journal-title":"Croat Med J"},{"key":"10.1007\/s13311-018-0640-5_bib136","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1684\/epd.2015.0778","article-title":"Mega-dose phenobarbital therapy for super-refractory status epilepticus","volume":"17","author":"Byun","year":"2015","journal-title":"Epileptic Disord"},{"key":"10.1007\/s13311-018-0640-5_bib137","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/NCC:4:1:035","article-title":"Literature review, case report, and expert discussion of prolonged refractory status epilepticus","volume":"4","author":"Robakis","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-018-0640-5_bib138","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1358\/dot.2008.44.1.1178468","article-title":"Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures","volume":"44","author":"Ben-Menachem","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"10.1007\/s13311-018-0640-5_bib139","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"H\u00f6fler","year":"2013","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S5189","article-title":"Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety","volume":"5","author":"Kellinghaus","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1007\/s13311-018-0640-5_bib141","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.yebeh.2011.02.006","article-title":"Atrioventricular block following lacosamide intoxication","volume":"20","author":"Krause","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"1\u20132","key":"10.1007\/s13311-018-0640-5_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2005.01.005","article-title":"Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trials","volume":"64","author":"Gidal","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib143","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.wnf.0000159956.87511.67","article-title":"Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy","volume":"28","author":"Otoul","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-018-0640-5_bib144","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","article-title":"Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study","volume":"259","author":"Misra","year":"2012","journal-title":"J Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1756285608100460","article-title":"New treatment options in status epilepticus: a critical review on levetiracetam","volume":"2","author":"Trinka","year":"2009","journal-title":"Ther Adv Neurol Dis"},{"issue":"suppl 1","key":"10.1007\/s13311-018-0640-5_bib146","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib147","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.WNL.0000042783.86439.27","article-title":"The use of topiramate in refractory status epilepticus","volume":"60","author":"Towne","year":"2003","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1007\/s13311-018-0640-5_bib148","first-page":"2314","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi","year":"2012","journal-title":"Brain"},{"key":"10.1007\/s13311-018-0640-5_bib149","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/11633090-000000000-00000","article-title":"Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study","volume":"26","author":"Hottinger","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1007\/s13311-018-0640-5_bib150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1528-1157.1997.tb01084.x","article-title":"Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus","volume":"38","author":"L\u00f6scher","year":"1997","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib151","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yebeh.2013.10.027","article-title":"Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus","volume":"31","author":"Patel","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-018-0640-5_bib152","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40265-017-0859-1","article-title":"Pharmacotherapy for refractory and super-refractory status epilepticus in adults","volume":"78","author":"Holtkamp","year":"2018","journal-title":"Drugs"},{"key":"10.1007\/s13311-018-0640-5_bib153","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000001717","article-title":"Status epilepticus of inflammatory etiology. A cohort study","volume":"85","author":"Spatola","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib154","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib156","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib157","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0035-1552625","article-title":"Autoimmune epilepsy","volume":"35","author":"Toledano","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib158","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib159","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib160","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush, a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib161","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000343739.72081.4e","article-title":"Potassium channels Brief overview and implications in epilepsy","volume":"72","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib162","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib163","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3174\/ajnr.A3633","article-title":"MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis","volume":"35","author":"Kotsenas","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1007\/s13311-018-0640-5_bib164","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib166","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-018-0640-5_bib167","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib168","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib169","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0896-6974(97)00053-4","article-title":"Phenobarbital and benzodiazepine assisted withdrawal of prolonged pentobarbital treatment for refractory status epilepticus","volume":"10","author":"Krishnamurthy","year":"1997","journal-title":"J Epilepsy"},{"key":"10.1007\/s13311-018-0640-5_bib170","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1528-1167.2011.03287.x","article-title":"The ketogenic and related diets in adolescents and adults \u2013 a review","volume":"52","author":"Payne","year":"2011","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-018-0640-5_bib171","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000000151","article-title":"Ketogenic diet for adults in super-refractory status epilepticus","volume":"82","author":"Thakur","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib172","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.0000000000003690","article-title":"Phase I\/II multicenter ketogenic diet study for adult superrefractory status epilepticus","volume":"88","author":"Cervenka","year":"2017","journal-title":"Neurology"},{"key":"10.1007\/s13311-018-0640-5_bib173","series-title":"Jasper's Basic Mechanisms of the Epilepsies [Internet]","article-title":"Neurosteroids \u2013 endogenous regulators of seizure susceptibility and role in the treatment of Epilepsy","author":"Reddy","year":"2012"},{"key":"10.1007\/s13311-018-0640-5_bib174","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib176","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/117.4.847","article-title":"Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex","volume":"117","author":"Pascual-Leone","year":"1994","journal-title":"Brain"},{"key":"10.1007\/s13311-018-0640-5_bib177","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.seizure.2013.06.014","article-title":"Transcranial magnetic stimulation for refractory focal status epilepticus in the intensive care unit","volume":"22","author":"Liu","year":"2013","journal-title":"Seizure"},{"key":"10.1007\/s13311-018-0640-5_bib178","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.clinph.2003.10.037","article-title":"Should transcranial magnetic stimulation research in children be considered minimal risk?","volume":"115","author":"Gilbert","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1007\/s13311-018-0640-5_bib179","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ncpneuro0530","article-title":"Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS","volume":"3","author":"Fregni","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1007\/s13311-018-0640-5_bib180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0920-1211(01)00252-2","article-title":"Neurosurgical treatment of medically intractable status epilepticus","volume":"46","author":"Ma","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-018-0640-5_bib181","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpn.2008.01.011","article-title":"Urgent, resective surgery for medically refractory, convulsive status epilepticus","volume":"13","author":"Schrader","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"issue":"suppl 8","key":"10.1007\/s13311-018-0640-5_bib182","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1167.2007.01353.x","article-title":"The surgical treatment of status epilepticus","volume":"48","author":"Lhatoo","year":"2007","journal-title":"Epilepsia"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-0640-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:52:26Z","timestamp":1761807146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":181,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1878747923010541"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-0640-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Refractory and Super-refractory Status Epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-0640-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}